China Universal Asset Management Company’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
China Universal Asset Management Company's PBYI Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Puma Biotechnology (PBYI) stake by 10% in Q2 2026, selling an estimated $6.79K and leaving 8,101 shares worth $65.7K. The position accounts for ﹤0.01% of the portfolio, ranked #445.
China Universal Asset Management Company first reported a position in PBYI in Q3 2022 and has held it in 4 quarters since. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.
- China Universal Asset Management Company held 8,101 shares of Puma Biotechnology worth $65.7K as of Q2 2026.
- China Universal Asset Management Company sold 927 Puma Biotechnology shares in Q2 2026, an estimated $6.79K.
- Puma Biotechnology made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #445 holding.
- China Universal Asset Management Company first reported a position in Puma Biotechnology in Q3 2022 and has held it in 4 quarters since.
- 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.